Track the 퓨쳐켐 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 퓨쳐켐 has recorded 51 public disclosures. Market capitalisation: €191.2bn. The latest transaction was filed on 21 September 2026 (Purchase). Among the most active insiders: 길희섭. The full history is openly available.
48
Insider Decl.
n/a
Thresholds
n/a
12 ops.
Buy Volume
n/a
26 ops.
Sell Volume
Fundamental score
Ranked 27,151 of 29,101 companies
18.0
score / 100
Value
20
Quality
16
FCF yld-5.7%
Earn yld-5.9%
EV/EBITDA·
ROE-19%
Gross mgn23%
Net mgn-60%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
퓨쳐켐 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for medical diagnosis and treatment.